Non-invasive Secondary Respiratory Support in Late Preterm and Term Infants

NCT07000071 — Not applicable, Completed, 40 participants, Alexandria University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT07000071
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, treatment
Enrollment40 (Actual)
SponsorAlexandria University (Other)
ConditionsNeonates, Respiratory Distress, Non- Invasive Ventilation
InterventionsNCPAP, NIPPV, NHFOV (Device)
Datesstart 2021-07-01, primary completion 2021-12-30, completion 2022-01-30, first posted 2025-05-31, last updated 2025-05-31
Locations1 site in Egypt

Related Papers Related Patents Related Grants Related Experts
All trials for Neonates All trials for Respiratory Distress All trials of NCPAP All trials of NIPPV

-Summary

The aim of the present work is to compare between various modes of non-invasive respiratory support (including NCPAP, NIPPV, and NHFOV) as secondary respiratory support modes in late preterm and term neonates as regards the need for reintubation. Additionally, the study aims at comparing between the three modes concerning the associated morbidity and mortality.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Nasal Continuous positive airway pressure (NCPAP)Active comparatorDevice: NCPAPapply continuous positive airway pressure using nasopharyngeal interface. positive end expiratory pressure (PEEP ) used 5-7 cm H2O. Neonates will be supported with NCPAP following extubation.
Nasal intermittent pressure ventilation (NIPPV)Active comparatorDevice: NIPPVNeonates will be supported with NIPPV following extubation.
Nasal high frequency ventilation (NHFOV)Active comparatorDevice: NHFOVNeonates will be supported with NHFOV following extubation. stating mean airway pressure 8 and can reach upto 15 cm H2O Delta pressure used is 20 Frequency 10 HZ
  • NCPAP (Device): Apply nasal continuous positive airway pressure in intubated patients with respiratory distress at time of weaning
  • NIPPV (Device): Apply nasal intermittent positive pressure ventilation in intubated patients with respiratory distress at time of weaning
  • NHFOV (Device): Apply nasal high frequency ventilation in intubated patients with respiratory distress at time of weaning

+Outcome measures

Primary outcomes

  • Failure rate [72 hours after weaning]: need for reintubation and invasive mechanical ventilation

Secondary outcomes

  • duration of non-invasive ventilation [first 72 hours after weaning from mechanical ventillation]: duration of noninvasive ventilation till patients become weaned to free flow oxygen

+Eligibility

Sex: All, ages: 1 Day to 14 Days, accepts healthy volunteers

Inclusion Criteria:

* The gestational age (GA) is between 34 and 41 weeks.
* Extubation from invasive mechanical ventilation initiated due to RD, irrespective to the cause of RD.
* Respiratory distress is assessed based on clinical manifestations (tachypnea, nasal flaring, intercostal retractions, diminished air entry, and or grunting)

Exclusion Criteria:

* Major congenital anomalies.
* Major cardiac diseases.
* Presence of cardiovascular instability (sepsis, severe dehydration, severe anemia).
* Neurologically insulted neonates who are unable to take adequate spontaneous breathing.

+Locations (1)

FacilityCityCountryStatus
Marwa Mohamed FaragAlexandriaEgypt